This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Helen of Troy (HELE) Tops Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Helen of Troy (HELE) delivered earnings and revenue surprises of 20.90% and 13.43%, respectively, for the quarter ended November 2020. Do the numbers hold clues to what lies ahead for the stock?
Will High Demand & Online Strength Continue to Aid Colgate (CL)?
by Zacks Equity Research
Despite cost and currency-related headwinds, strong product demand and sturdy online show are likely to help Colgate (CL) stay put amid this COVID-19 crisis.
Here's Why You Should Add Procter & Gamble (PG) to Your Portfolio
by Zacks Equity Research
Procter & Gamble (PG) has been gaining from strong demand for its products, underlying strength in brands and appropriate strategies. Also, cost-saving initiatives bode well.
Helen of Troy (HELE) to Report Q3 Earnings: What's in Store?
by Zacks Equity Research
Helen of Troy's (HELE) third-quarter fiscal 2021 results are likely to reflect strength in Leadership brands and online sales. However, unfavorable currency rates are a concern.
Earnings Preview: Helen of Troy (HELE) Q3 Earnings Expected to Decline
by Zacks Equity Research
Helen of Troy (HELE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Factors That Make Helen of Troy (HELE) a Solid Pick for 2021
by Zacks Equity Research
Helen of Troy (HELE) is focused on making solid investments in Leadership Brands. Also, strength in the online business is yielding positive results.
Helen of Troy's (HELE) New Revlon License to Boost Beauty Business
by Zacks Equity Research
Helen of Troy Limited (HELE), via its subsidiaries, enters into a 100-year exclusive Trademark License Agreement with Revlon to license the trademark for hair care appliances and tools of the latter.
Helen of Troy (HELE) Up 6.9% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Helen of Troy (HELE) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Helen of Troy (HELE) Earnings & Sales Beat Estimates in Q2
by Zacks Equity Research
Helen of Troy's (HELE) second-quarter fiscal 2021 results reflect better-than-expected sales and earnings on strength across all segments, along with gains in online business.
Coty to Gain From Kylie Skin International DTC Website Launch
by Zacks Equity Research
Coty (COTY) unveils the launch of Kylie Skin's direct-to-consumer flagship website in global markets, including France, Germany, the United Kingdom and Australia.
Helen of Troy (HELE) Tops Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Helen of Troy (HELE) delivered earnings and revenue surprises of 57.74% and 18.70%, respectively, for the quarter ended August 2020. Do the numbers hold clues to what lies ahead for the stock?
All You Should Know Before Helen of Troy's (HELE) Q2 Earnings
by Zacks Equity Research
Helen of Troy's (HELE) second-quarter fiscal 2021 results are likely to reflect strength in Leadership brands and online sales.
Nu Skin (NUS) Rallies on Impressive Sales Projection for Q3
by Zacks Equity Research
Nu Skin (NUS) anticipates third-quarter 2020 revenues in the range of $700-$703 million ahead of its previously provided guidance.
Strength Seen in Nu Skin (NUS): Stock Soars 9.6%
by Zacks Equity Research
Nu Skin (NUS) saw a big move last session, as its shares jumped nearly 10% on the day, amid huge volumes.
Helen of Troy (HELE) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Helen of Troy (HELE) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Can Helen of Troy (HELE) Keep the Earnings Surprise Streak Alive?
by Zacks Equity Research
Helen of Troy (HELE) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Here is Why Growth Investors Should Buy Helen of Troy (HELE) Now
by Zacks Equity Research
Helen of Troy (HELE) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Sanderson Farms' (SAFM) Shareholder-Friendly Moves Look Solid
by Zacks Equity Research
Sanderson Farms (SAFM), which recently raised its quarterly dividend, is benefiting from its strategic growth efforts.
Colgate Up More Than 10% YTD on Demand: Will It Move Higher?
by Zacks Equity Research
Colgate (CL) remains well placed with strong product demand, robust pricing efforts and sturdy online show, which are boosting organic sales. However, costs and currency-related headwinds persist.
Nu Skin is Poised on Customer Base Growth & Product Pipeline
by Zacks Equity Research
Strength in Nu Skin's (NUS) customer base driven by its effective strategies is yielding. Also, it is focused on empowering sales leaders through engaging technology platforms.
Coronavirus-Led Woes Hurt Coty (COTY), E-commerce Looks Solid
by Zacks Equity Research
Weakness in the Consumer Beauty segment along with currency headwinds are a concern for Coty (COTY). Nevertheless, its strategic partnerships and online business bode well.
Zacks Industry Outlook Highlights: Helen of Troy, Nu Skin, Inter Parfums, e.l.f. Beauty and Estee Lauder
by Zacks Equity Research
Zacks Industry Outlook Highlights: Helen of Troy, Nu Skin, Inter Parfums, e.l.f. Beauty and Estee Lauder
NUS or HELE: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
NUS vs. HELE: Which Stock Is the Better Value Option?
4 Cosmetics Stocks to Buff Up Your Portfolio Amid Industry Challenges
by Zacks Equity Research
The Zacks Cosmetics industry is facing COVID-19 woes like disturbed travel retail, low traffic and soft makeup demand. Rising demand for personal care products however bodes well for HELE, NUS, IPAR and ELF, which are focused on adapting to the changing market trends.
4 Factors That Make Helen of Troy (HELE) a Promising Stock
by Zacks Equity Research
Helen of Troy (HELE) is gaining on digital efforts and strength in Leadership Brands. The company's Health & Home segment is benefiting from pandemic-led demand.